D61 Other aplastic anemias and other bone marrow failure syndromes
D61 is the ICD-10-CM code family for Other aplastic anemias and other bone marrow failure syndromes: 13 codes, all of which can lead a home health claim, 1 of those with a code-first note.
Codes in family
13
Can lead a claim
13
Cannot lead a claim
0
What CMS assigns to D61
All 13 codes group to MMTA - Infectious Disease, Neoplasms, and Blood-Forming Diseases. All 13 count toward the Hemolytic, Aplastic, and Other Anemias comorbidity subgroup. Every code can lead a claim. CMS attaches a code-first note to 1 of the 13.
- Hemolytic, Aplastic, and Other Anemias: can award the low comorbidity tier as a secondary diagnosis.
Code first
CMS grouper convention 8, on D61.2. Code first:
- , if applicable, toxic effects of substances chiefly nonmedicinal as to source (T51-T65)
Every code in D61
Descriptions are CDC’s FY2027 wording; where CMS’s grouper abbreviates one, its form is shown beneath.
| Code | Description | Primary position | Clinical group | Comorbidity subgroup |
|---|---|---|---|---|
| D61.0 Constitutional aplastic anemia | ||||
| D61.01 | Constitutional (pure) red blood cell aplasia | Can lead a claim | K | Hemolytic, Aplastic, and Other Anemias |
| D61.02 | Shwachman-Diamond syndrome | Can lead a claim | K | Hemolytic, Aplastic, and Other Anemias |
| D61.03 | Fanconi anemia | Can lead a claim | K | Hemolytic, Aplastic, and Other Anemias |
| D61.09 | Other constitutional aplastic anemia | Can lead a claim | K | Hemolytic, Aplastic, and Other Anemias |
| D61.1 | Drug-induced aplastic anemia | Can lead a claim | K | Hemolytic, Aplastic, and Other Anemias |
| D61.2 | Aplastic anemia due to other external agents | Can lead a claim, code first applies | K | Hemolytic, Aplastic, and Other Anemias |
| D61.3 | Idiopathic aplastic anemia | Can lead a claim | K | Hemolytic, Aplastic, and Other Anemias |
| D61.8 Other specified aplastic anemias and other bone marrow failure syndromes | ||||
| D61.81 Pancytopenia | ||||
| D61.810 | Antineoplastic chemotherapy induced pancytopenia | Can lead a claim | K | Hemolytic, Aplastic, and Other Anemias |
| D61.811 | Other drug-induced pancytopenia | Can lead a claim | K | Hemolytic, Aplastic, and Other Anemias |
| D61.818 | Other pancytopenia | Can lead a claim | K | Hemolytic, Aplastic, and Other Anemias |
| D61.82 | Myelophthisis | Can lead a claim | K | Hemolytic, Aplastic, and Other Anemias |
| D61.89 | Other specified aplastic anemias and other bone marrow failure syndromesCMS: Oth aplastic anemias and other bone marrow failure syndromes | Can lead a claim | K | Hemolytic, Aplastic, and Other Anemias |
| D61.9 | Aplastic anemia, unspecified | Can lead a claim | K | Hemolytic, Aplastic, and Other Anemias |
Sources: CMS HH PPS Grouper Software (opens in a new tab) v07.2.26, effective 2026-10-01, for the clinical group, comorbidity subgroup, code-first conventions and primary-position flags; CDC NCHS ICD-10-CM FY2027 (opens in a new tab) code descriptions for the family title and code wording. This is the crosswalk Medicare runs a claim through. Grouping also depends on admission source, timing, the OASIS functional items and the rest of the diagnosis list.